CStone Pharmaceuticals (“CStone” or the “Company”, HKEX: 2616) announced that the China National Medical Products Administration (NMPA) has accepted the…
Browsing: BioTech
TOT BIOPHARM International Company Limited (“TOT BIOPHARM” or the “Company”; stock code: 1875.HK) is pleased to announce that the randomized…
Path-Away(R), a plant-based natural active ingredient used in the alcohol-free NatShield(TM) hand sanitiser developed by Malaysia-based and Australia-listed Holista CollTech…
Australian-listed companies Skin Elements Limited (ASX: SKN) (‘Skin Elements’) and Holista Colltech Limited (ASX:HCT) (‘Holista’) announced today a Binding Collaboration…
Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary…
TOKYO – (ACN Newswire) – On March 6th Azabu Insights proposed a theory that coronavirus seemed to be spreading faster in cold countries than…
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has expanded its lab facilities by more than 30% to accommodate…
Award-winning global leader in digital patient recruitment GeoMap Clinical by TrialWire announced today new tools added to the GeoMap geo-targeting…
On 6 March 2020, a morale-enhancing conference themed “Working Towards a World-class High-tech ePark & a New Summit for Reform…
A group of consultants at Azabu Insights Inc., a strategic consulting company in Azabu Juban Tokyo, have been analyzing data…
Professor Li Hongjun, Chairman of the Professional Committee of Infectious Disease Radiology of the Chinese Medical Association Radiology Branch and…
AIM ImmunoTech (NYSE American: AIM, or the Company), an immuno-pharma company focused on the research and development of therapeutics to…
Captiva Verde Land Corp. (CSE: PWR) (OTC: CPIVF) (the “Company” or “Captiva”), is pleased to announce the following updates for…
Just 4 weeks of chiropractic adjustment stimulating proprioception helps people deal with physical pain and annoying dizziness, according to a…
Aptorum Group Limited (“Aptorum Group”), a pharmaceutical company focused on the development of novel therapeutics to address global unmet medical…
1. Targeted by a short seller, China Medical System fought back with…
Holista CollTech (ASX:HCT) (“Holista”) announced today it will co-develop and produce in Malaysia the world’s first nasal sanitising balm using…
Holista將含Path-Away(R)成分的消毒液的分銷範圍擴展至東盟，英國和歐洲 Holista CollTech（ASX代碼：HCT）（以下簡稱“Holista”或本公司）今日宣布，它將在馬來西亞與合作夥伴一起共同研發和生產世界上第一款使用Path-Away®製成的鼻香膏。 Path-Away®是一種基於植物的不含酒精的活性成分，已被證明可以殺死所有先前已知的冠狀病毒，且不會對人造成傷害。 Path-Away®由Global Infection Control Consultants LLC（以下簡稱“ GICC LCC”）研發，該成分已被證明可殺死170多種病原體（包括病毒，細菌和真菌）。它可以殺死艾滋病毒以及極其頑固的結核分枝桿菌。馬來西亞衛生部批准其對H1N1病毒有效。 GICC LLC由其總裁兼首席研究科學家Arthur Martin博士創立，位於南卡羅來納州布盧夫頓。 共同為全球市場研發鼻香消毒膏 Martin博士和Holista創始人兼首席執行官Rajen Manicka博士共同宣布：“Covid-19疫情爆發後，兩家公司將擴大合作夥伴關係，並加快包含Path-Away®鼻香消毒膏的研發。” 兩家公司預計將於2020年第一季度共同申請鼻香消毒膏的全球專利，併計劃於2020年第三季度開始生產，然後在英國和歐洲的冬季開始前將其分銷至全球分銷。 鼻香膏將含有Path-Away®成分，它是由GICC LLC專有的一系列獨立工廠和工藝製成的。…
DNX Biopharmaceuticals, a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with life-long diseases and a resident…
While the world attention is on the fight against Coronavirus in China, Blue Orca is concerned about other things at…